Approval · Notice of Compliance 4106 · 1997
PENTA-VALPROIC: Notice of Compliance 4106
Issued May 15, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4106
- Date
- May 15, 1997
- Company
- Pentapharm Ltd.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Anticonvulsant
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PENTA-VALPROIC | 02231248 | Cancelled (Unreturned Annual) |
Medicinal ingredients
- VALPROIC ACID 250 MG per CAP